PortfoliosLab logo
Ryman Healthcare Ltd ADR (RYHTY)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US78391Y1082

Highlights

Market Cap

$1.49B

EPS (TTM)

-$0.37

PEG Ratio

2.46

Year Range

$7.20 - $15.37

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Ryman Healthcare Ltd ADR

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Ryman Healthcare Ltd ADR (RYHTY) returned -46.24% year-to-date (YTD) and -33.48% over the past 12 months. Over the past 10 years, RYHTY returned -11.24% annually, underperforming the S&P 500 benchmark at 10.85%.


RYHTY

YTD

-46.24%

1M

0.46%

6M

-48.38%

1Y

-33.48%

3Y*

-38.84%

5Y*

-27.47%

10Y*

-11.24%

^GSPC (Benchmark)

YTD

0.51%

1M

6.15%

6M

-2.00%

1Y

12.92%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of RYHTY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-9.44%-30.30%-8.39%-7.45%0.46%-46.24%
2024-3.75%-20.17%-2.53%-11.78%-7.14%0.86%17.04%14.94%-8.77%8.01%-4.76%-3.98%-24.99%
202331.84%-19.82%-7.99%-0.33%15.96%6.20%3.91%-6.09%-3.62%-16.65%5.54%9.29%7.94%
2022-22.99%4.78%-3.60%-8.38%8.89%-11.19%2.03%0.04%-12.10%-5.79%-9.85%-21.26%-58.64%
20211.97%-2.96%-2.40%-4.98%-8.10%-0.95%-1.04%20.01%-4.39%0.26%-19.75%0.81%-23.07%
2020-5.89%-5.57%-38.91%20.24%5.44%5.62%11.41%0.25%2.08%0.39%13.37%5.77%-0.22%
2019-3.11%4.49%8.24%-1.18%-8.20%5.30%17.37%-11.94%2.97%-1.26%10.62%27.64%55.32%
201813.76%-5.53%-0.21%-3.69%8.71%2.21%2.57%10.81%0.76%-15.23%1.19%-6.06%5.91%
201712.93%0.45%-8.36%-0.46%5.28%9.63%-2.69%2.94%-6.21%14.66%-0.14%28.48%
2016-0.41%1.90%9.63%5.28%4.72%4.86%-0.60%5.45%0.55%-11.88%-3.46%-4.10%10.58%
2015-9.79%-0.23%-1.49%6.10%-9.77%-2.76%3.20%-1.39%-14.83%11.57%-2.32%2.30%-20.23%
20141.22%-0.99%13.41%1.59%-4.23%4.19%-0.87%-9.75%-7.52%-2.11%7.35%4.91%5.09%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RYHTY is 7, meaning it’s performing worse than 93% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RYHTY is 77
Overall Rank
The Sharpe Ratio Rank of RYHTY is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of RYHTY is 66
Sortino Ratio Rank
The Omega Ratio Rank of RYHTY is 55
Omega Ratio Rank
The Calmar Ratio Rank of RYHTY is 1010
Calmar Ratio Rank
The Martin Ratio Rank of RYHTY is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Ryman Healthcare Ltd ADR (RYHTY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Ryman Healthcare Ltd ADR Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: -0.83
  • 5-Year: -0.81
  • 10-Year: -0.43
  • All Time: -0.39

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Ryman Healthcare Ltd ADR compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Ryman Healthcare Ltd ADR provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%1.00%2.00%3.00%4.00%$0.00$0.20$0.40$0.60$0.8020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.00$0.00$0.44$0.71$0.80$0.72$0.76$0.74$0.65$0.59$0.50$0.51

Dividend yield

0.00%0.00%2.43%4.18%1.90%1.29%1.34%2.00%1.84%2.08%1.93%1.54%

Monthly Dividends

The table displays the monthly dividend distributions for Ryman Healthcare Ltd ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.44$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.44
2022$0.00$0.00$0.00$0.00$0.00$0.44$0.00$0.00$0.00$0.00$0.00$0.27$0.71
2021$0.00$0.00$0.00$0.00$0.00$0.49$0.00$0.00$0.00$0.00$0.00$0.31$0.80
2020$0.00$0.00$0.00$0.00$0.00$0.41$0.00$0.00$0.00$0.00$0.00$0.31$0.72
2019$0.00$0.00$0.00$0.00$0.00$0.39$0.00$0.00$0.00$0.00$0.00$0.37$0.76
2018$0.00$0.00$0.00$0.00$0.00$0.38$0.00$0.00$0.00$0.00$0.00$0.37$0.74
2017$0.00$0.00$0.00$0.00$0.33$0.00$0.00$0.00$0.00$0.00$0.33$0.65
2016$0.00$0.00$0.00$0.00$0.00$0.29$0.00$0.00$0.00$0.00$0.30$0.00$0.59
2015$0.00$0.00$0.00$0.00$0.00$0.26$0.00$0.00$0.00$0.00$0.00$0.24$0.50
2014$0.27$0.00$0.00$0.00$0.00$0.00$0.25$0.51

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Ryman Healthcare Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ryman Healthcare Ltd ADR was 86.86%, occurring on Mar 25, 2025. The portfolio has not yet recovered.

The current Ryman Healthcare Ltd ADR drawdown is 86.59%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.86%Feb 10, 2021545Mar 25, 2025
-67.14%Jan 9, 202024Mar 23, 202054Jan 8, 202178
-37.32%May 9, 201461Sep 15, 2015153Jan 5, 2018214
-21.93%Oct 2, 201829Jan 30, 201965Dec 4, 201994
-9.21%Feb 6, 201820Apr 26, 201811Jun 8, 201831
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ryman Healthcare Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Ryman Healthcare Ltd ADR, comparing actual results with analytics estimates.


0.000.050.100.150.20AprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2021FebruaryMarchAprilMayJune
0.19
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how Ryman Healthcare Ltd ADR is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for RYHTY compared to other companies in the Medical Care Facilities industry. RYHTY currently has a PEG ratio of 2.5. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RYHTY relative to other companies in the Medical Care Facilities industry. Currently, RYHTY has a P/S ratio of 2.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for RYHTY in comparison with other companies in the Medical Care Facilities industry. Currently, RYHTY has a P/B value of 0.6. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items